Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 4/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.35 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | TNF | P01375 | 5/20 | 0.32 |
| ▸ | LITAF | Q99732 | 5/20 | 0.32 |
| ▸ | USP7 | Q93009 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872980 | 1.00 | PDE4B (0.35) | PDE4BSLC2A1AVPR1BHTR2CKCNH2 | |
| SCHEMBL871464 | 0.93 | TNF (0.34) | PDE4BPDE4DTNFLITAFUSP7 | |
| SCHEMBL871465 | 0.93 | TNF (0.34) | PDE4BPDE4DTNFLITAFUSP7 | |
| SCHEMBL870835 | 0.91 | TNF (0.33) | PDE4BPDE4DPDE4APDE4CTNF | |
| SCHEMBL870836 | 0.91 | TNF (0.33) | PDE4BPDE4DPDE4APDE4CTNF | |
| SCHEMBL872002 | 0.89 | METAP2 (0.36) | PDE4BKCNH2PDE4DP2RY1TNF | |
| SCHEMBL872001 | 0.89 | METAP2 (0.36) | PDE4BKCNH2PDE4DP2RY1TNF | |
| SCHEMBL870540 | 0.89 | TNF (0.32) | PDE4BPDE4DTNFLITAFUSP7 | |
| SCHEMBL870539 | 0.89 | TNF (0.32) | PDE4BPDE4DTNFLITAFUSP7 | |
| SCHEMBL870327 | 0.89 | TNF (0.32) | PDE4BMCHR1PDE4DPRCPTNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | ALCON RESEARCH, LTD. | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077801-A1 | Chemical Compounds 637 | PDE4A, PDE4B, PDE3B | PDE4B 2/4885SLC2A1 3666/4885AVPR1B 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.